Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • NPPA allows companies...

    NPPA allows companies to withdraw stent from market

    Written by Ruby Khatun Khatun Published On 2018-02-22T15:34:04+05:30  |  Updated On 22 Feb 2018 3:34 PM IST
    NPPA allows companies to withdraw stent from market

    New Delhi: Drug price regulator NPPA said it has decided not to stop any coronary stent manufacturer from withdrawing products from the Indian market.


    The National Pharmaceutical Pricing Authority (NPPA) said however that the companies will have to follow the mandatory requirement of informing it six months in advance as prescribed under Drugs Prices Control Order (DPCO), 2013, while also following the ceiling price.


    "In this connection, it is informed that NPPA has in-principle decided not to disallow any application submitted for withdrawal of stents from the market by stent manufacturer/importers," NPPA said in an office memorandum.


    Under DPCO 2013, a manufacturer is required to inform NPPA at least six months prior to the intended date of discontinuation and also "follow ceiling price in such a manner and till such a time prescribed the government".


    Last week, the government had revised ceiling prices of bare metal stents and drug-eluting ones, almost a year after it slashed rates of coronary stents by up to 85 percent. In case of bare metal stents (BMS), the government has increased the prices from current Rs 7,400 to Rs 7,660. On the other hand price of drug-eluting stents (DES) has come down to Rs 27,890 from Rs 30,180.


    Read also: Govt Revision of Stent prices: Industry woes but Consumers Rejoice


    In April last year, the NPPA had rejected applications by multinational firms Abbott and Medtronic to withdraw their advanced coronary stents from India while asking them to maintain supplies of the products.


    Read also: Govt rejects Abbott, Medtronic applications to withdraw stents


    The authority had asked the companies to consider options for price revision before deciding to withdraw their products from the market.


    Prior to that, the NPPA had brought stents under price control and capped ceiling price of coronary stents at Rs 7,260 for bare metal variety and Rs 29,600 for drug-eluting ones.


    Read also: Stent Prices Capped at Rs 29,600, profits slashed


    Below is the attached notification.

    Abbottallowbare metal stentsceiling pricesCoronary StentsDPCODrug Eluting StentsDrugs Prices Control OrderIndian marketMedtronicNational Pharmaceutical Pricing AuthorityNPPAStentstent makersStentswithdrawal
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok